Filing Details
- Accession Number:
- 0001181431-14-022020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-02 13:34:58
- Reporting Period:
- 2014-05-29
- Filing Date:
- 2014-06-02
- Accepted Time:
- 2014-06-02 13:34:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 927066 | Davita Healthcare Partners Inc. | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1458379 | Laura Mildenberger | C/O Davita Healthcare Partners Inc. 2000 16Th Street Denver CO 80202 | Chief People Ofcr, Kidney Care | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-29 | 9,375 | $31.70 | 16,109 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-05-29 | 4,295 | $69.20 | 11,814 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-05-29 | 5,080 | $69.99 | 6,734 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2014-05-29 | 9,375 | $0.00 | 9,375 | $31.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,500 | 2011-03-31 | 2015-03-31 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price of $69.9861. The range of prices for the sale of these shares was $69.92 - $70.09, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- Stock Appreciation Rights, granted on 3/31/2010, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.
Billionaire Hedge Funds
